Company · Healthtech & Bio

53Biologics

53biologics.com ↗ ·Valladolid ·Other

53Biologics is a Spanish contract development and manufacturing organization (CDMO) based in Valladolid specializing in biologics production, from plasmid DNA and mRNA components to recombinant proteins, offering cell line development, analytical and process development, and GMP manufacturing from preclinical through commercial stages. Founded in 2017 as a biopharmaceutical subsidiary of the BDi Biotechnology Group, it has raised venture funding from Inveready and GAEA Inversión and in 2026 took on a majority-stake investment from European private equity firm Ren Life Sciences to expand its GMP biomanufacturing capacity.

Founded

2017

Founders

News

Rounds

Investors

SectorsBiotechnology, CDMO, Biologics Manufacturing, Life Sciences Start-up MapHealthtech & Bio › Biologics manufacturing & CDMO

Profile updated 19 Jul 2026

Founders

Pablo Gutiérrez Gómez

CEO & Founder

Global models 5

National Resilience

United States · resilience.com ↗

A large-scale biomanufacturing CDMO offering end-to-end drug substance and biologics production infrastructure, directly comparable to 53Biologics' contract manufacturing model.

$2.0BComparable

ElevateBio

United States · elevate.bio ↗

Combines a biotech platform with its own BaseCamp CDMO facilities for cell and gene therapy and biologics manufacturing, similar to 53Biologics' development-plus-manufacturing offering.

$1.3BComparable

Cellares

United States · cellares.com ↗

An integrated development and manufacturing organization (IDMO) automating biologics/cell therapy production at scale, matching 53Biologics' CDMO service model.

$612MComparable

Aldevron

United States · www.aldevron.com ↗

The world's largest cGMP plasmid DNA manufacturer, essentially the same core plasmid DNA CDMO business as 53Biologics before being acquired by Danaher for $9.6B.

$250M (VC/PE, pre-acquisition)Comparable

Absci

United States · www.absci.com ↗

A biologics company combining recombinant protein development with manufacturing services, paralleling 53Biologics' recombinant protein and process development work.

$225MComparable

Investors 3

GAEA Inversión

www.gaeainversion.com ↗

Investor Spain

Inveready

inveready.com

Investor Spain

Ren Life Sciences

renlifesciences.com ↗

Investor United Kingdom

Funding rounds 2

Other

Valladolid-based GMP biomanufacturing company 53Biologics raised an undisclosed amount in a round led by European private equity firm Ren Li…

2026-03-25

Series A · €7M

GAEA Inversión and Inveready Biotech III jointly invested €7M, paid in tranches, in Biotechnology Developments for Industry (BDI) to grow it…

2021-09-10

News & media 5

Published	Article
2026-03-25	53Biologics drives its expansion in GMP biomanufacturing with an investment led by Ren Life Sciences and supported by Inveready ↗ Biotech Spain
2024-10-11	53Biologics, la vallisoletana que ayuda a las pequeñas compañías a desarrollar terapias innovadoras ↗ El Economista
2024-09-26	53Biologics Awarded Best Company in Biotechnology Innovation at Farmaforum ↗ AseBio
2023-05-10	53Biologics Unveils New GMP Production Line for Biologics ↗ Contract Pharma
2023-03-17	53Biologics Expands its State-of-the-art Facilities ↗ Contract Pharma